Literature DB >> 17853953

Granuloma-positive Crohn's disease.

Hugh J Freeman1.   

Abstract

BACKGROUND: The epithelioid granuloma is a characteristic histological feature of Crohn's disease. In some pathological classification schemes, the criteria for a definite, probable or possible diagnosis have been listed, with the epithelioid granuloma indicating definite Crohn's disease.
METHODS: In the present evaluation, 247 prospectively evaluated Crohn's disease patients (24.3%), from a consecutively accumulated population database of 1015 patients, were found to have an epithelioid granuloma. The recently devised Montreal classification for Crohn's disease was then applied to this granuloma-positive cohort of Crohn's disease patients to define age at diagnosis for men and women, disease site and disease behaviour.
RESULTS: The investigation showed that patients with Crohn's disease and granulomas were most often diagnosed early in the course of their disease, particularly women. Their disease was often extensive, with ileocolonic and upper gastrointestinal tract involvement. Finally, disease behaviour was most often complex, especially with penetrating disease complications.
CONCLUSION: Using homogeneous (ie, 'reagent-grade') patient cohorts defined by a recently devised classification method for Crohn's disease, the study demonstrated that an epithelioid granuloma may represent a histopathological marker for an early biological event in the etiopathogenesis of Crohn's disease, and this may have predictive significance with respect to the location and clinical behaviour of Crohn's disease.

Entities:  

Mesh:

Year:  2007        PMID: 17853953      PMCID: PMC2657987          DOI: 10.1155/2007/917649

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  24 in total

1.  Clinical significance of granuloma in Crohn's disease.

Authors:  Nizar N Ramzan; Jonathan A Leighton; Russell I Heigh; Michael S Shapiro
Journal:  Inflamm Bowel Dis       Date:  2002-05       Impact factor: 5.325

2.  A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

Authors:  C Gasche; J Scholmerich; J Brynskov; G D'Haens; S B Hanauer; E J Irvine; D P Jewell; D Rachmilewitz; D B Sachar; W J Sandborn; L R Sutherland
Journal:  Inflamm Bowel Dis       Date:  2000-02       Impact factor: 5.325

3.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

4.  Risk factors for initial surgery in pediatric patients with Crohn's disease.

Authors:  Neera Gupta; Stanley A Cohen; Alan G Bostrom; Barbara S Kirschner; Robert N Baldassano; Harland S Winter; George D Ferry; Terry Smith; Oren Abramson; Benjamin D Gold; Melvin B Heyman
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

5.  Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

6.  Application of the Vienna Classification for Crohn's disease to a single clinician database of 877 patients.

Authors:  H J Freeman
Journal:  Can J Gastroenterol       Date:  2001-02       Impact factor: 3.522

7.  Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease.

Authors:  D Heresbach; J L Alexandre; B Branger; J F Bretagne; E Cruchant; A Dabadie; M Dartois-Hoguin; P M Girardot; H Jouanolle; J Kerneis; J C Le Verger; V Louvain; J Politis; M Richecoeur; M Robaszkiewicz; J A Seyrig
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

8.  Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease.

Authors:  M Pierik; G De Hertogh; S Vermeire; G Van Assche; P Van Eyken; S Joossens; G Claessens; R Vlietinck; P Rutgeerts; K Geboes
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

9.  Granulomatous ulcerative colitis: a re-appraisal of the mucosal granuloma in the distinction of Crohn's disease from ulcerative colitis.

Authors:  U Mahadeva; J P Martin; N K Patel; A B Price
Journal:  Histopathology       Date:  2002-07       Impact factor: 5.087

10.  Familial Crohn's disease in single or multiple first-degree relatives.

Authors:  Hugh J Freeman
Journal:  J Clin Gastroenterol       Date:  2002-07       Impact factor: 3.062

View more
  18 in total

1.  Predictors of aggressive inflammatory bowel disease.

Authors:  Andres J Yarur; Sebastian G Strobel; Amar R Deshpande; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

2.  Segmental colitis associated with diverticulosis syndrome.

Authors:  Hugh-James Freeman
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

3.  Long-term natural history of Crohn's disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

4.  An Expandable Mechanopharmaceutical Device (2): Drug Induced Granulomas Maximize the Cargo Sequestering Capacity of Macrophages in the Liver.

Authors:  Phillip Rzeczycki; Gi Sang Yoon; Rahul K Keswani; Sudha Sud; Jason Baik; Mikhail D Murashov; Ingrid L Bergin; Kathleen A Stringer; Gus R Rosania
Journal:  Pharm Res       Date:  2018-11-07       Impact factor: 4.200

Review 5.  Relevance of segmental colitis with diverticulosis (SCAD) to other forms of inflammatory bowel disease.

Authors:  H J Freeman
Journal:  Can J Gastroenterol       Date:  2009-06       Impact factor: 3.522

Review 6.  Natural history and long-term clinical course of Crohn's disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

7.  Histopathological findings of extra-ileal manifestations at initial diagnosis of Crohn's disease-related ileitis.

Authors:  Ian S Brown; Gregory C Miller; Mark L Bettington; Christophe Rosty
Journal:  Virchows Arch       Date:  2016-09-03       Impact factor: 4.064

8.  Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naïve patients with Crohn's disease.

Authors:  Kyoichi Kato; Ken Fukunaga; Koji Kamikozuru; Shinichiro Kashiwamura; Nobuyuki Hida; Yoshio Ohda; Naohisa Takeda; Koji Yoshida; Masaki Iimuro; Yoko Yokoyama; Risa Kikuyama; Hiroto Miwa; Takayuki Matsumoto
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

9.  Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production.

Authors:  Dave R Dobis; Richard T Sawyer; May M Gillespie; Lee S Newman; Lisa A Maier; Brian J Day
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-09       Impact factor: 6.914

10.  Natural history and long-term clinical behavior of segmental colitis associated with diverticulosis (SCAD syndrome).

Authors:  Hugh J Freeman
Journal:  Dig Dis Sci       Date:  2008-03-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.